FDA Webview
X
about-us-banner

Articles

Home /Articles / FDA Federal Register Notices

Pediatric Subcommittee to Discuss Anticoagulant Products

09/21/2011

Federal Register Notice: FDA’s Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee will meet 11/2, fro...

Risk Communication Panel to Meet

09/21/2011

Federal Register Notice: FDA’s Risk Communication Advisory Committee will meet 11/17, from 8 a.m. to 5 p.m. and 11/18, from ...

Animal Drug Sponsor Name Changed

11/10/2010

Federal Register Final rule: FDA is amending the animal drug regulations to reflect a change of sponsor's name from North American...

Amphetamine Sulfate Not Withdrawn for S&E

11/10/2010

Federal Register Notice: FDA has determined that amphetamine sulfate, 5 and 10 mg tablets, was not withdrawn from sale for reasons...

Special Control Guidance Available for Tissue Adhesive

11/10/2010

Federal Register Notice: FDA is making available a guidance entitled, Class 2 Special Controls Guidance Document: Tissue Adhesive ...

Comments Extended on PDUFA Reauthorization Meeting

11/10/2010

Federal Register Notice: FDA is reopening until 10/31/11 the comment period for the notice of public meeting that published in the...

FDA Classifies Tissue Adhesive into Class 2

11/10/2010

Federal Register Final rule: FDA is classifying the tissue adhesive with adjunct wound closure device intended for topical approxi...

FDA Science Board Nominees Sought

10/20/2010

Federal Register Notice: FDA is requesting nominations for voting members from academia and industry to serve on the Science Board...

Guidance on INDs with Live Biotherapeutic Products

10/14/2010

Federal Register Notice: FDA is making available a draft document, Guidance for Industry: Early Clinical Trials with Live Biothera...

FDA OKs Pharmacia & Upjohn sNADA for Dairy Cows

10/14/2010

Federal Register Final rule: FDA is amending the animal drug regulations to reflect approval of a Pharmacia & Upjohn supplemental ...